Immunization and Vaccines Development

Print

The Immunization and Vaccines Development Programme provides technical support to countries in the African Region in order to contribute to the reduction of disease, disability and death due to vaccine preventable diseases.


 Ministers pledge to improve access to vaccines at first-ever Ministerial Conference on Immunization in Africa
Ministers pledge to improve access to vaccines at first-ever Ministerial Conference on Immunization in AfricaAddis Ababa, 25 February 2016 – With one in five African children lacking access to all needed and basic life-saving vaccines, ministers of health and other line ministers countries committed themselves to keep immunization at the forefront of efforts to reduce child mortality, morbidity and disability.

At a landmark Ministerial Conference on Immunization in Africa held from 24-25 February, in Addis Ababa, Ethiopia the ministers signed a declaration to promote the use of vaccines to protect people of all ages against vaccine-preventable diseases and to close the immunization gap by 2020. The conference, which was hosted by the World Health Organization (WHO) Regional Offices for Africa (AFRO) and the Eastern Mediterranean (EMRO) in conjunction with the African Union Commission (AUC), was the first-ever ministerial-level gathering with a singular focus on ensuring that children across the continent can get access to life-saving vaccines.

 Despite gains in access, 1 in 5 African children go without lifesaving vaccines
Despite gains in access, 1 in 5 African children go without lifesaving vaccinesAddis Ababa, 23 February 2016 — A new report issued today by the World Health Organization (WHO) Regional Office for Africa and the Eastern Mediterranean Region shows that despite considerable progress in expanding access to vaccines in Africa, one in five children on the continent still do not receive life-saving immunizations. Africa’s routine immunization coverage of 80% is the lowest of any region in the world.  

The report is being released ahead of the first-ever Ministerial Conference on Immunization in Africa, being held in Addis Ababa on 24-25 February, which will bring together ministers of health and other line ministers as well as parliamentarians to commit to providing universal access to immunization and strengthening of vaccine delivery systems

 Meningitis A nearly eliminated in Africa through vaccination, reaching more than 235 million people
Children standing in line to get vaccinated – Meningitis vaccine launch – Burkina Faso, 2010
Addis Ababa, 23 February 2016 - Global vaccine experts and officials from all 26 African “meningitis belt” countries have convened in Addis Ababa, Ethiopia to celebrate one of Africa’s biggest public health achievements—the introduction of a vaccine, MenAfriVac®, designed, developed, and produced for use in Africa, that in five years of use has nearly eliminated serogroup A meningococcal disease from meningitis belt countries and is now being integrated into routine national immunization programs.

WHO Director-General, Dr. Margaret Chan (2nd from left), the WHO Regional Director for Africa, Dr. Matshidiso Moeti (3rd from right), the Executive Director of Nigeria Primary Health Care Development Agency, Dr. Ado Mohammed (centre) with Nigerian Government delegation, and the WHO Polio Eradication Programme Coordinator for African Region, Dr. Pascal Mkanda (far right) at the announcement of Nigeria removal from polio endemic list of countriesNew York, 25 September 2015 | The Director-General of the World Health Organization (WHO), Dr. Margaret Chan announced the removal of Nigeria, the then only remaining endemic country in the African Region, from the list of polio endemic countries at the Polio Oversight Board Meeting in New York, USA. This was a historic occasion for polio eradication in Nigeria, Africa and globally.

Topics

Integrated child survival interventions

Measles elimination

Monitoring and evaluation

Polio eradication

 



Reach every district (RED) approach

Tetanus elimination

Vaccine research and development

Yellow fever control